AngioDynamics Financials
| ANGO Stock | USD 9.87 0.47 5.00% |
AngioDynamics |
Understanding current and past AngioDynamics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AngioDynamics' financial statements are interrelated, with each one affecting the others. For example, an increase in AngioDynamics' assets may result in an increase in income on the income statement.
AngioDynamics Stock Summary
AngioDynamics competes with AptarGroup, Repro Med, AtriCure, Akoya Biosciences, and ICU Medical. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people.Specialization | Healthcare, Medical Instruments & Supplies |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US03475V1017 |
| CUSIP | 03475V101 |
| Location | New York; U.S.A |
| Business Address | 14 Plaza Drive, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.angiodynamics.com |
| Phone | 518 795 1400 |
| Currency | USD - US Dollar |
AngioDynamics Key Financial Ratios
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.0584 | ||||
| Target Price | 15.33 | ||||
| Number Of Employees | 748 | ||||
| Beta | 0.56 |
AngioDynamics Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AngioDynamics competition to find correlations between indicators driving AngioDynamics's intrinsic value. More Info.AngioDynamics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.AngioDynamics Systematic Risk
AngioDynamics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AngioDynamics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on AngioDynamics correlated with the market. If Beta is less than 0 AngioDynamics generally moves in the opposite direction as compared to the market. If AngioDynamics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AngioDynamics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AngioDynamics is generally in the same direction as the market. If Beta > 1 AngioDynamics moves generally in the same direction as, but more than the movement of the benchmark.
AngioDynamics Thematic Clasifications
AngioDynamics is part of Cancer Fighters investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases
This theme covers Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Get More Thematic Ideas
| Cancer Fighters | View |
AngioDynamics March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AngioDynamics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AngioDynamics. We use our internally-developed statistical techniques to arrive at the intrinsic value of AngioDynamics based on widely used predictive technical indicators. In general, we focus on analyzing AngioDynamics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AngioDynamics's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.12 | |||
| Information Ratio | 0.0518 | |||
| Maximum Drawdown | 46.09 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 4.93 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.